Physician profile
Rushabh Prakash Dev
NPI 1255719274
$9,030.35
in general payments reported to CMS, 2019-2025
14 companies · $6,271 in 2025
The $6,271 reported for 2025 was more than what 91% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $53.69 · 2022: $290 · 2023: $188 · 2024: $1,713 · 2025: $6,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $2,134 · Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $2,134.17 |
| Food and Beverage | $537.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,873.13 | 2023-2025 | Da Vinci Surgical System |
| Teleflex LLC | $268.61 | 2022 | |
| Boston Scientific Corporation | $230.05 | 2023-2024 | Spyglass, Spyglass Discover, Exalt Model D |
| Acell, INC. | $145.90 | 2019-2020 | |
| Kci USA, INC. | $137.61 | 2019-2020 | |
| Avita Medical Americas, LLC | $123.99 | 2019 | |
| Polynovo North America LLC | $71.73 | 2022-2024 | Novosorb Btm |
| Allergan, INC. | $61.58 | 2019-2020 | |
| Tetraphase Pharmaceuticals, INC. | $41.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.98 | 2025 | Ribfix Titan |
| Kls-Martin L.P. | $16.60 | 2019 | |
| Tactile Systems Technology INC | $15.64 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.71 | 2019 | |
| Incyte Corporation | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rushabh Dev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.